Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                MCM Legal, Regulatory and Policy Framework

MCM Legal, Regulatory and Policy Framework

                        Emergency Use Authorization
          Expiration Dating Extension
          MCM Emergency Use Authorities
          MCM-Related Counterterrorism Legislation
          MCM-Related Legal and Policy Presentations, Publications and Q&As
          State, Tribal, Local, and Territorial Public Health Preparedness
          Guidance and Other Information of Special Interest to MCM Stakeholders
          MCM-Related Cooperative Arrangements
          Availability of Regulatory Management Plans
          Vaccine EUA Questions and Answers for Stakeholders
          FAQs: What happens to EUAs when a public health emergency ends? Home
          Emergency Preparedness and Response
          Counterterrorism and Emerging Threats
          Medical Countermeasures Initiative (MCMi)
          MCM Legal, Regulatory and Policy Framework
          MCM-Related Legal and Policy Presentations, Publications and Q&AsMCM Legal, Regulatory and Policy Framework MCM-Related Legal and Policy Presentations, Publications and Q&As
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintImage
              Stethoscope with booksFDA continues to ensure that U.S. laws, regulations, and policies enable the application of advances in regulatory science to the regulatory review process for medical countermeasures (MCMs).

We also support preparedness for and response to chemical, biological, radiological, nuclear (CBRN), and emerging infectious disease threats by facilitating the availability of MCMs and working with state and local authorities to support preparedness and response capabilities at the state and community levels.

The resources below provide updates on FDA activities to support the MCM-related legal and policy framework, to better protect national health and security. The following documents and presentations discuss MCM legal preparedness and response issues, including Emergency Use Authorizations.

Meetings and Presentations

Medical Products Post-Public Health Emergency: Emergency Use Authorizations and the Transition to a New Normal (PDF, 480 KB)
	May 2023: Elizabeth Sadove and Jean McCue present at the Food and Drug Law Institute Annual Conference
	FDA’s EUAs and Other Related Authorities (PDF, 940 KB)
	November 2021: Regulatory counsel, Elizabeth Sadove presents at BARDA Industry Day
	FDA’s EUAs and Other Related Authorities (PDF, 158 KB)
	May 2021: Regulatory counsel, Jennifer Ross presents at the 2021 PMDA Spring Symposium
	Overview from FDA - Tri-Agency Task Force for Emergency Diagnostics Session (PDF, 692 KB)
	April 2021: Regulatory counsel, Jennifer Ross presents at the 2021 Preparedness Summit
	Overview of FDA’s Emergency Use Authorization (EUA) Authority & COVID-19 Response (PDF, 438 KB)
	March 2021: Regulatory Counsel, Brooke Courtney presents at the American Bar Association Health Law Section
	Overview of FDA’s Emergency Use Authorization (EUA) Authority(PDF, 403.36 KB)
	March 2021: Regulatory Counsel, Brooke Courtney presents at the CSTE Public Health Law Webinar: Implications for COVID-19 Vaccination
	Emergency Response Authorities and Access to Medical Countermeasures (PDF, 654.36 KB)
	February 2021: Regulatory Counsel, Brooke Courtney presents at the PHEP Connects WebinarArchived meetings and presentations (2020 and older)
	Emergency Response Authorities and Access to Medical Countermeasures FDA-CDC Joint Learning Session: Regulatory Updates on Use of Medical Countermeasures (PDF, 862.91 KB) [ARCHIVED]
	August 2020: Regulatory Counsel, Elizabeth Sadove presents at the Preparedness Summit
	Beyond the Last Mile: Monitoring and Assessing Medical Countermeasure Use in Response to Public Health Emergencies (PDF, 1.6 MB) [ARCHIVED]
	May 2018: Regulatory Counsel, Greg Measer presents at the NASEM Biosecurity luncheon
	Emergency Use of Medical Countermeasures: FDA Roles and Authorities (PDF, 1.8 MB) [ARCHIVED]
	February 2018: FDA OCET presentation as part of the University of Arizona Regulatory Science Series
	FDA Roles in Supporting the Emergency Use of Medical Countermeasures (PDF, 495 KB) [ARCHIVED]
	January 2018: Presented at the National Interagency Confederation for Biological Research – Scientific Interaction Subcommittee (NICBR-SIS) Winter Forum
	Extending Expiration Dates of Stockpiled Doxycycline for Anthrax Preparedness
	September 2017: CDC and FDA hosted a webinar to discuss FDA’s draft guidance Extending Expiration Dates of Doxycycline Tablets and Capsules in Strategic Stockpiles. A recording, slides and Q and A are available in CDC TRAIN (free account required).
	Beyond the Last Mile: Monitoring and Assessing Medical Countermeasure Use in Response to Public Health Emergencies (PDF, 1.5 MB) [ARCHIVED]
	April 2017: FDA OCET presentation at the Preparedness Summit
	Emergency Legal Preparedness Summit (YouTube) April 2017: Video recording of a panel of public health preparedness experts, including FDA, examining critical challenges in emergency legal preparedness and policy at Georgetown University Law Center (2 hours, 16 minutes)
	Emergency Legal Preparedness and FDA Response to Zika Virus (PDF, 1.4 MB) [ARCHIVED]
	December 2016: FDA OCET presentation at the American Bar Association Washington Health Summit
	FDA's Medical Countermeasure Role in Preparedness and Response (PDF, 549 KB) [ARCHIVED]
	September 2016: FDA OCET presentation at the National Biosurveillance Integration Center Interagency Biosurveillance Presentation Series and Information-Sharing Forum
	ZIKA VIRUS and Emergency Legal Preparedness: FDA Zika Response Efforts (PDF, 152 KB) [ARCHIVED]
	September 2016: FDA OCET presentation at the National Public Health Law Conference Washington, DC
	Expedited Development Programs and Emergency Access Mechanisms (PDF, 130 KB) [ARCHIVED]
	April 2016: FDA OCET presentation UTMB-FDA Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories
	Federal Updates on the Emergency Use of MCMs: EUAs, EUIs, and Beyond (PDF, 655 KB) [ARCHIVED]
	April 2015: FDA OCET presentations at the Preparedness Summit
	PAHPA Reauthorization and Federal Legal Preparedness Updates (PDF, 318 KB) [ARCHIVED]
	October 2014: FDA OCET presentations at the Public Health Law Conference
	MCM Policy Updates Following the 2013 Enactment of PAHPRA (PDF, 344 KB) [ARCHIVED]
	June 2014: Presentation from the 12th Annual Emerging Infectious Diseases Biodefense conference
	FDA Legal Preparedness Tools for Distributing and Dispensing Medical Countermeasures (PDF - 777 KB) [ARCHIVED]
	October 12, 2012: 2012 Public Health Law Conference (prior to PAHPRA)
	Federal, State, and Local Public Health Preparedness Legal and Regulatory Meeting [ARCHIVED]
	December 14-15, 2010 (prior to PAHPRA)


Publications

Public Health Emergencies: Unpacking Medical Countermeasures Management for Preparedness and Response
	Measer GT, Maher CT, Hu-Primmer J. Am J Public Health. 2018 Sep;108(S3):S224-S226.
	Medical Countermeasures: Emergency Preparedness and Response Roles and Authorities (book chapter)
	Courtney B, Sadove E. Medical Countermeasures: Emergency Preparedness and Response Roles and Authorities, in FOOD AND DRUG LAW AND REGULATION (3rd ed. 2015) (David G. Adams, Richard M. Cooper, Martin J. Hahn, Jonathan S. Kahan, eds.).
	Regulatory Underpinnings of Global Health Security: FDA's Roles in Preventing, Detecting, and Responding to Global Health Threats (open access article)
	Courtney B, Bond K., Maher C. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. September/October 2014, 12(5): 239-246. doi:10.1089/bsp.2014.0046.
	Federal legal preparedness tools for facilitating medical countermeasures use during public health emergencies
	Courtney B, Sherman S, Penn M. Federal legal preparedness tools for facilitating medical countermeasures use during public health emergencies. Journal of Law, Medicine, & Ethics. 2013 Mar;41 Suppl 1:22-7. doi: 10.1111/jlme.12033.
	Meeting the challenges of medical countermeasure development (open access article)
	Maher C, Hu-Primmer J, MacGill T, Courtney B, Borio L. Meeting the challenges of medical countermeasure development. Microbial Biotechnology 2012;5(5):588-593.Question and Answer Documents

FAQs: What happens to EUAs when a public health emergency ends? (April 2022)
	Vaccine EUA Questions and Answers for Stakeholders(December 2020)
	PAHPRA Q and A for Public Health Preparedness and Response Stakeholders (PDF, 250 KB) [ARCHIVED]Related Links



MCMi Publications and Reports
	MCMi News and Events
	Pediatric Medical Countermeasures
	MCMi Collaborations

                                                                                  Content current as of:
      05/24/2023
              
              
Topic(s)
			  Drug Shortage
				    				       				    				       Terrorism
				       				    				       Radiological
				       				    				       Outbreak
				       				    				       Chemical
				       				    				       BiologicalLaw(s) & Regulation(s)
			  21st Century Cures Act of 2016
			    			       			    			       Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA)MCM Legal, Regulatory and Policy Framework

          
                        Emergency Use Authorization
          Expiration Dating Extension
          MCM Emergency Use Authorities
          MCM-Related Counterterrorism Legislation
          MCM-Related Legal and Policy Presentations, Publications and Q&As
          State, Tribal, Local, and Territorial Public Health Preparedness
          Guidance and Other Information of Special Interest to MCM Stakeholders
          MCM-Related Cooperative Arrangements
          Availability of Regulatory Management Plans
          Vaccine EUA Questions and Answers for Stakeholders
          FAQs: What happens to EUAs when a public health emergency ends?
 Subscribe
                        Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop